Riboflavin reduces hyperalgesia and inflammation but not tactile allodynia in the rat

European Journal of Pharmacology

Volumn 492, Issue 1, 2004, Pages 35-40

  Granados Soto, Vinicio ^a   Terán Rosales, Flavio ^b   Rocha González, Héctor I ^a   Reyes García, Gerardo ^b   Medina Santillán, Roberto ^b   Rodríguez Silverio, Juan ^b,c   Flores Murrieta, Francisco J ^b,c  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c SECRETARÍA DE SALUD   (Mexico)

Author keywords

Allodynia; B vitamin; Hyperalgesia; Riboflavin

Indexed keywords

CARRAGEENAN; FORMALDEHYDE; GABAPENTIN; GLIBENCLAMIDE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE; OPIATE; POTASSIUM CHANNEL; POTASSIUM ION; RIBOFLAVIN;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; EXPERIMENTAL RAT; FEMALE; HYPERALGESIA; INFLAMMATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS; ANIMALS; CARRAGEENAN; ENZYME INHIBITORS; FEMALE; GLYBURIDE; HYPERALGESIA; INFLAMMATION; MOTOR ACTIVITY; NALOXONE; NARCOTIC ANTAGONISTS; NG-NITROARGININE METHYL ESTER; PAIN MEASUREMENT; PAIN THRESHOLD; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, WISTAR; RIBOFLAVIN;

EID: 2442560316     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.03.043     Document Type: Article

References (31)

1. Aguirre-Bañuelos P., Granados-Soto V. Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociception of meloxicam in the formalin test. Eur. J. Pharmacol. 395:2000;9-13
2. Backonja M., Glanzman R.L. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin. Ther. 25:2003;81-104
3. Bartoszyk G.D., Wild A. B-vitamins potentiate the antinociceptive effect of diclofenac in carrageenan-induced hyperalgesia in the rat tail pressure test. Neurosci. Lett. 101:1989;95-100
4. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods. 53:1994;55-63
5. Daly J.W., Shi D., Padgett W.L., Ji X.-D., Jacobson K.A. Riboflavin: inhibitory effects on receptors, G-proteins, and adenylate cyclase. Drug Dev. Res. 42:1998;98-108
6. Dirig D.M., Salami A., Rathbun M.L., Ozaki G.T., Yaksh T.L. Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli. J. Neurosci. Methods. 76:1997;183-191
7. + channels. Annu. Rev. Pharmacol. Toxicol. 33:1993;597-637
8. 12 and aspirin in three experimental pain models in rats and mice. Psychopharmacology. 81:1983;228-231
9. França D.S., Souza A.L.S., Almeida K.R., Dolabella S.S., Martinelli C., Coelho M.M. B vitamins induce an antinociceptive effect in the acetic acid and formaldehyde models of nociception in mice. Eur. J. Pharmacol. 421:2001;157-164
10. Granados-Soto V., Flores-Murrieta F.J., Castañeda-Hernández G., López-Muñoz F.J. Evidence for the involvement of nitric oxide in the antinociceptive effect of ketorolac. Eur. J. Pharmacol. 277:1995;281-284
11. Hanck A., Weiser H. Analgesic and anti-inflammatory properties of vitamins. Int. J. Vitam. Nutr. Res., Suppl. 27:1985;189-206
12. Ialenti A., Ianaro A., Moncada S., Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol. 211:1992;177-182
13. Islas-Cadena M., Aguirre-Bañuelos P., Granados-Soto V. Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociception of nimesulide in the formalin test. J. Pharmacol. Toxicol. Methods. 42:1999;87-92
14. Jurna I., Carlson K.H., Bonke D., Fu Q.G., Zimmermann M. Suppression of thalamic and spinal nociceptive neuronal response by pyridoxine, thiamin, and cyanocobalamin. Ann. N. Y. Acad. Sci. 585:1990;492-495
15. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363
16. Lashbrook J.M., Ossipov M.H., Hunter J.C., Raffa R.B., Tallarida R.J., Porreca F. Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1- and COX2-inhibitors in nerve-injured rats. Pain. 82:1999;65-72
17. + channel pathway in the antinociceptive action of ketorolac. Eur. J. Pharmacol. 426:2001;41-46
18. Leuschner J. Antinociceptive properties of thiamin, pyridoxine and cyanocobalamin following repeated oral administration to mice. Arzneimittelforschung. 42:1992;2114-2115
19. Malmberg A.B., Yaksh T.L. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J. Pharmacol. Exp. Ther. 263:1992;136-146
20. Marcus R., Coulston A.M. Water-soluble vitamins. The vitamin B complex and ascorbic acid. Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., Gilman A.G. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 1996;1555-1572 McGraw-Hill, New York
21. + channels by diclofenac. Eur. J. Pharmacol. 438:2002;85-91
22. + channels. Pharmacol. Biochem. Behav. 74:2003;465-470
23. Reyes-García G., Medina-Santillán R., Terán-Rosales F., Mateos-García E., Castillo-Henkel C. Characterization of the potentiation of the antinociceptive effect of diclofenac by vitamins B complex in the rat. J. Pharmacol. Toxicol. Methods. 42:1999;73-77
24. Schoenen J. Anti-migraine treatment: present and future. Rev. Med. Liege. 54:1999;79-86
25. Schoenen J., Lenaerts M., Bastings E. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia. 14:1994;328-329
26. Schoenen J., Jacquy J., Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis: a randomized controlled trial. Neurology. 50:1998;466-470
27. Scholte H.R., Busch H.F., Bakker H.D., Bogaard J.M., Luyt-Houwen I.E., Kuyt L.P. Riboflavin-responsive complex I deficiency. Biochim. Biophys. Acta. 1271:1995;75-83
28. Wheeler-Aceto H., Cowan A. Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology. 104:1991;35-44
29. Winder C.W., Wax J., Been M.A. Rapid foot volume measurements on unanesthetized rats and the question of a phenylbutazone effect on anaphylactoid edema. Arch. Int. Pharmacodyn. 112:1957;174-182
30. Wyatt K.M., Dimmock P.W., Jones P.W., O'Brien S.P.M. Efficacy of vitamin B6 in the treatment of premenstrual syndrome. Systematic review. Br. Med. J. 318:1999;1375-1381
31. Zimmermann M. Ethical guidelines for investigations on experimental pain in conscious animals. Pain. 16:1983;109-110